- Report
- August 2021
- 274 Pages
Global
From €4754EUR$4,950USD£4,093GBP
- Report
- May 2019
- 835 Pages
Global
From €8164EUR$8,500USD£7,029GBP
- Report
- April 2022
Europe, Global, United States, ... Europe, Global, United States, Japan
From €2641EUR$2,750USD£2,274GBP
- Report
- December 2021
Global
From €4658EUR$4,850USD£4,010GBP
- Report
- March 2021
- 220 Pages
Global
From €3362EUR$3,500USD£2,894GBP
- Report
- February 2020
- 230 Pages
Japan, United States, ... Japan, United States, Europe, Global
From €4322EUR$4,500USD£3,721GBP
- Report
- July 2019
- 835 Pages
Global
From €8164EUR$8,500USD£7,029GBP
The Campylobacter Test market is a segment of the Infectious Disease Testing industry. It is used to detect the presence of Campylobacter bacteria, which can cause gastrointestinal illness. Tests are typically performed on stool samples, and can be used to diagnose an infection, monitor treatment, or detect the presence of the bacteria in food or water. Tests are available in both laboratory-based and point-of-care formats.
The Campylobacter Test market is highly competitive, with a range of companies offering products. These include bioMérieux, Becton Dickinson, Cepheid, DiaSorin, Hologic, Meridian Bioscience, Quidel, and Thermo Fisher Scientific. Show Less Read more